Jinfeng Cai

4PUBLICATIONS

22CO-AUTHORS

Molecular targetsCriminological theoriesGene and molecular therapyRegenerative medicine (incl. stem cells)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Aug 03, 2026

Sorafenib enforces HIV-1 latency by selectively inhibiting PKC-driven STAT1/3 serine 727 phosphorylation.

|Jun 03, 2026

HIV-1 infection converts CD4+ T cells to HLA class II-restricted CD8+ T cells.

|May 22, 2023

Ponatinib Represses Latent HIV-1 by Inhibiting AKT-mTOR.

Ting Huang, Jinfeng Cai, Peipei Wang

|Apr 09, 2021

Infection with a newly designed dual fluorescent reporter HIV-1 effectively identifies latently infected CD4+ T cells.

Jinfeng Cai, Hongbo Gao, Jiacong Zhao

Pageof 1

Frequent Collaborators

Kai Deng

Wei Dong

Peipei Wang

Jiacong Zhao

Xinyu Liang

Zhuoyue Meng

Wei Wang

Jiasheng Zhou

Haixiang Peng

Huixin Wu

Frequent Collaborators

Kai Deng

Wei Dong

Peipei Wang

Jiacong Zhao